These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Therapy of tparkinson's disease. Clinical and pharmacological viewpoints]. Przuntek H Med Klin; 1979 Jul; 74(28-29):1077-83. PubMed ID: 39230 [No Abstract] [Full Text] [Related]
24. How to achieve maximum benefit for the patient with Parkinson's disease. Greer M Geriatrics; 1976 Apr; 31(4):89-96. PubMed ID: 4356 [No Abstract] [Full Text] [Related]
25. A comparative study of bromocriptine and levodopa in Parkinson's disease. Duvoisin RC; Mendoza MM; Yahr MD Adv Biochem Psychopharmacol; 1980; 23():271-5. PubMed ID: 7395618 [No Abstract] [Full Text] [Related]
26. Recent developments in the treatment of Parkinson's disease. Greer M Geriatrics; 1985 Feb; 40(2):34-8, 41. PubMed ID: 2857148 [TBL] [Abstract][Full Text] [Related]
27. [Parkinson disease. The clinical picture and therapy]. Huber M Dtsch Med Wochenschr; 1988 Jun; 113(24):992-8. PubMed ID: 2897901 [No Abstract] [Full Text] [Related]
28. [Therapy of Parkinson's syndrome]. Clemens R Dtsch Med Wochenschr; 1976 Mar; 101(11):420-3. PubMed ID: 767084 [No Abstract] [Full Text] [Related]
29. Parkinson's disease: new treatments. Stewart RM Compr Ther; 1981 Apr; 7(4):38-44. PubMed ID: 7237986 [TBL] [Abstract][Full Text] [Related]
30. The treatment of parkinsonism. Godwin-Austen R Practitioner; 1975 Oct; 215(1288):445-51. PubMed ID: 1202468 [No Abstract] [Full Text] [Related]
31. Drug management of Parkinson's disease. Kishore A; Snow BJ Can Fam Physician; 1996 May; 42():946-52. PubMed ID: 8688697 [TBL] [Abstract][Full Text] [Related]
32. Treating parkinsonism in the era of levodopa. McFarland HR Am Fam Physician; 1975 Sep; 12(3):99-104. PubMed ID: 240264 [No Abstract] [Full Text] [Related]
33. Update on antiparkinsonian agents. Weiner M Geriatrics; 1982 Sep; 37(9):81-4, 89-91. PubMed ID: 6125455 [No Abstract] [Full Text] [Related]
34. Comparative study of selegiline plus L-dopa-carbidopa versus L-dopa-carbidopa alone in the treatment of Parkinson's disease. Brannan T; Yahr MD Ann Neurol; 1995 Jan; 37(1):95-8. PubMed ID: 7818264 [TBL] [Abstract][Full Text] [Related]
36. Controversies in the management of Parkinson's disease. Calne DB; Rinne UK Mov Disord; 1986; 1(3):159-62. PubMed ID: 3143065 [No Abstract] [Full Text] [Related]
37. Management of Parkinson's disease in general practice. Wilson JA Scott Med J; 1986 Apr; 31(2):132-4. PubMed ID: 3738478 [No Abstract] [Full Text] [Related]
38. The Sydney multicentre study of Parkinson's disease. The first 18 months. Hely MA; Morris JG; Rail D; O'Sullivan DJ; Williamson PM; Genge S; Reid WG; Broe GA Med J Aust; 1987 Feb; 146(4):195-8. PubMed ID: 3553878 [TBL] [Abstract][Full Text] [Related]
39. Low-dosage treatment in de novo patients with Parkinson's disease: a prospective study. van der Drift JH Adv Neurol; 1987; 45():529-34. PubMed ID: 3825731 [TBL] [Abstract][Full Text] [Related]